StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Seloken / Toprol-XL (metoprolol) by Quarter

Seloken / Toprol-XL (metoprolol) — Europe YoY actual (%) (%)

QuarterlyAnnual

AstraZeneca Seloken / Toprol-XL (metoprolol): -1.0% in Q2 2026, down 5.0 pts from a year earlier.

Latest, Q2 2026
-1.0%
Period ended Jun 30, 2026
Change on a year earlier
-5.0 pts
4.0% in Q2 2025
History
21 quarters
Since Q4 2020
Sources
21
Documents cited below

Where the Q2 2026 figure comes from

“|| Seloken | 157 | | 6 | | 2 | | - | | - | | 153 | | 6 | | 2 | | 3 | | ( 1 ) | | ( 3 ) | | 1 | | 12 | | 4”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Product Sales Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSeloken / Toprol-XL (metoprolol) — Europe YoY actual (%) (%)Year on yearSource
Q2 2026Jun 30, 2026-1.0%-5.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 202610.0%-60.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 202537.0%+57.0 ptsForm 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 202562.0%–Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 20254.0%-42.0 ptsForm 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 202570.0%+93.0 ptsForm 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024-20.0%-3.0 ptsForm 6-K FY2024Q4 Earnings Release ↗
Q2 2024Jun 30, 202446.0%+62.0 ptsForm 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024-23.0%-26.0 ptsForm 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023-17.0%–Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023-45.0%-54.0 ptsForm 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023-16.0%-13.0 ptsForm 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20233.0%-10.0 ptsForm 6-K FY2023Q1 Earnings Release ↗
Q3 2022Sep 30, 20229.0%+34.0 ptsForm 6-K FY2022Q3 Earnings Release ↗
Q2 2022Jun 30, 2022-3.0%+17.0 ptsForm 6-K FY2022Q2 Earnings Release ↗
Q1 2022Mar 31, 202213.0%+39.0 ptsForm 6-K FY2022Q1 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Seloken / Toprol-XL (metoprolol) (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-seloken-eu-act-yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.